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Study Objective: To provide estimates of the costs and health outcomes implications of the excess risk of
unexpected disposition for nurse anesthetist (NA) procedures.
Design: A projection model was used to apply estimates of costs and health outcomes associated with the
excess risk of unexpected disposition for NAs reported in a recent study.
Setting: Ambulatory and inpatient surgery.
Patients: Base-case model parameters were based on estimates taken from peer-reviewed publications
when available, or from other sources including data for all hospital stays in the United States in 2013 from
the Healthcare Cost and Utilization Project Web site. The impact of parameter uncertainty was assessed
using 1-way and 2-way sensitivity analyses.
Interventions: Not applicable.
Measurements: Major complication rates, relative risks of complications, anesthesia costs, costs of
complications, and cost-effectiveness ratios.
Main Results: In the base-case model, there were on average 2.3 fewer unexpected dispositions for physician
anesthesiologists compared with NAs. Overall, anesthesia-related costs (including the cost of managing unexpected
dispositions) were estimated to be about $31 higher per procedure for physician anesthesiologists compared with
NAs. Alternativemodel scenarios in the sensitivity analysis produced estimates of smaller additional costs associated
with physician anesthesia administration, to the point of cost savings in some scenarios.
Conclusions: Provision of anesthesia for ambulatory knee and shoulder procedures by physician anesthesiologists
results in better health outcomes, at a reasonable additional cost, comparedwith procedureswithNA-administered
anesthesia, at least when using updated cost-effectiveness willingness-to-pay benchmarks.
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158 R.L. Ohsfeldt et al.1. IntroductionThe role of certiﬁed registered nurse anesthetists (NAs) in
the provision of anesthesia services for surgery in the United
States has grown over the last few decades, with NAs aug-
menting or substituting for anesthesiology services provided
by physician anesthesiologists [1]. Based on calculations using
the National Plan and Provider Enumeration System database
containing all National Provider Identiﬁer (NPI) numbers, as
of December 2016, there were 48,647 unique NPIs for active
NAs and 46851 NPIs for active physicians listing anesthesiol-
ogy as a primary specialty, with an additional 3117 listing
anesthesiology-pain medicine as a primary specialty [2].
Although NAs generally have been shown to safely and ef-
fectively provide a range of anesthesiology services under the
supervision of physician anesthesiologists [3-8], the rising role
of NAs in the provision of anesthesia care has sparked some
concern about the potential impact of the quality of anesthesia
services [4,9,10]. For example, in a study examining
performance managing a set of simulated intraoperative emer-
gencies, Henrichs et al. [4] found that board-certiﬁed physi-
cian anesthesiologists achieved a modestly higher mean
overall performance score than NAs (66.6% ± 11.7% vs
59.9% ± 10.2%; P b .01). Similarly, Silber et al. [9] found
higher rates of death and failure-to-rescue when anesthesia
care was not directed by physician anesthesiologists (odds
ratio for death, 1.08; P b .04; odds ratio for failure-to-rescue,
1.10; P b .01), but no statistically signiﬁcant difference in
complication rates (odds ratio for complication, 1.00;
P b .79). This corresponds to 2.5 excess deaths/1000 patients
and 6.9 excess failures-to-rescue (deaths) per 1000 patients
with complications.
In a recent study focused on outcomes for ambulatory sur-
gical procedures, Memtsoudis et al. [11] examined whether
patient characteristics, ambulatory facility type, anesthesia
provider and technique, procedure type, and temporal factors
impact the outcome of unexpected disposition after ambulato-
ry knee and shoulder surgery. Unexpected disposition was de-
ﬁned as either an admission to a hospital or death following
ambulatory surgery, but death as an outcome was too rare to
be analyzed as a separate end point. Their results indicated that
a factor independently increasing the risk for unexpected
disposition was the type of anesthesia provider. Speciﬁcally,
the reported relative risk for unexpected disposition for
anesthesia provided by NAs vs physician anesthesiologists
was 1.38 (P b .01) for knee procedures and 1.79 (P b .01)
for shoulder procedures.
Although the literature indicates a lower risk of unexpected
disposition after ambulatory knee and shoulder surgery when
anesthesia is provided by physician anesthesiologists com-
pared with NAs, the cost impact or cost-effectiveness of this
reduction is largely absent from the literature. The objective
of present study is to ﬁll this gap by using estimates of the
excess risk of unexpected disposition after ambulatory knee
and shoulder surgery associated with anesthesia administeredby NAs compared with physician anesthesiologists (reported
by Memtsoudis et al.) to generate estimates of the cost and ef-
fectiveness implications of unexpected dispositions. Estimates
of resource costs and health-related quality of life obtained
from the literature are used to project the differences in overall
costs for anesthesia administered by NAs compared with phy-
sician anesthesiologists in relation to differences in treatment
effectiveness (ie, outcomes). Outcomes are estimated alterna-
tively as “hospitalizations avoided” or “quality-adjusted life-
years (QALYs) gained” from fewer unexpected dispositions
with physician administered anesthesia.2. Materials and methods
Base-case model parameters are derived from estimates in
published peer-reviewed studies when available, but in
some instances when no speciﬁc data from the literature are
available, reasonable assumptions are used for base-case
parameters. The impact of parameter uncertainty is assessed
using both 1-way and 2-way discrete sensitivity analyses for
key model parameters.
The base-case model parameters relating to rates of serious
complications for ambulatory knee and shoulder surgery are
reported in Table 1, along with their sources. The base-case pa-
rameter estimates relating to the relative risk of unexpected
disposition are taken from the study by Memtsoudis et al. To
facilitate subsequent cost analysis, we specify a ratio of 1 phy-
sician anesthesiologist for 4 NAs (1:4 ratio) to represent the
mix for the nonspeciﬁc physician/NA team category in the
study by Memtsoudis et al. Studies by Lovald et al. [12], Gill
et al. [13], andMartin et al. [14] provide additional detail about
the likelihood of serious complications, including death.
However, the base-case model assumes no differences in rates
for “other” serious complications associated with type of anes-
thesia provider.
Similarly, base-case cost parameters and their sources are
reported in Table 2. Estimates of professional service costs
by type of anesthesia provider are taken from Hogan et al.
[15], inﬂated to 2014 dollars using the Consumer Price
Index—all items [16]. Gonano et al. [17] provide base-case
parameter estimates for anesthesia supply costs, which are
assumed to be the same for all types of anesthesia providers.
The base-case value of the cost of an unexpected admission
is derived from data for all hospital stays in the United States in
2013 from theHealthcare Cost and Utilization Project (HCUP)
Web site [18]. After excluding all neonatal and maternal hos-
pital stays, HCUP's online database query tool, H⋅CUPNet
(http://hcupnet.ahrq.gov/), generated an estimatedmean length
of stay (LOS) of 4.9 days for 2013, with a mean cost per
stay of $12,539 in 2013 dollars ($12,742 after inﬂated to
2014 dollars). Simply dividing the mean total cost per stay
by the mean LOS yields an estimate of $2600 per inpatient
day. To be conservative, for our base-case cost estimate, we
assume that the mean LOS for unexpected hospitalizations
Table 1 Base-case parameter assumptions, complication rates.
Base Sources
Major complication rates
Knee
Any 5.8%
Unexpected admission 3.8% [11]
Other major 1.7% [12]
Death 0.28% [11,13]
Shoulder
Any 9.9%
Unexpected admission 7.9% [11]
Other major 1.7% A
Death 0.25% [13,14]
Relative risks of complication, knee
Unexpected admission
Physician anesthesiologist–alone 1 [11]
Physician-directed NA—1:4 0.931 [11]
NA-alone 1.379 [11]
Death
Physician anesthesiologist–alone 1 A
Physician-directed NA—1:4 1 A
NA-alone 1 A
Relative risks of complication, shoulder
Unexpected admission
Physician anesthesiologist–alone 1 [11]
Physician-directed NA—1:4 1.339 [11]
NA-alone 1.786 [11]
Death
Physician anesthesiologist–alone 1 A
Physician-directed NA—1:4 1 A
NA-alone 1 A
A = authors' assumption; NA = nurse anesthetist.
Table 2 Base-case parameter assumptions, costs.
Base Sources
Anesthesia costs (2014$)
Professional services
Physician anesthesiologist–alone $369 [16,17]
Physician-directed NA—1:4 $294 [16,17]
NA-alone $187 [16,17]
Drugs, supplies
Physician anesthesiologist–alone $95 [17,18]
Physician-directed NA—1:4 $95 [17,18]
NA-alone $95 [17,18]
Costs of complications (2014$)
Major complication, knee
Unexpected admission
Cost per inpatient day $2600 [17,19]
No. of days 2.5 [19]
Postdischarge recovery ($/d) $20 A
Postdischarge recovery days 0.0 A
Other major $1000 A
Death $2000 A
Major complication, shoulder
Unexpected admission
Cost per inpatient day $2600 [17,19]
No. of days 2.5 [19]
Postdischarge recovery ($/d) $20 A
Postdischarge recovery days 0.0 A
Other major $1250 A
Death $2000 A
A = authors' assumption; NA = nurse anesthetist.
159Cost of unexpected disposition by anesthesia providerwas 2.5 days (about half the national average for all inpatient
stays excluding neonatal and maternal stays). It is likely that
the average costs per day for a stay of 2.5 days would exceed
the average cost per day for a stay of 4.9 days. Indeed, Taheri
et al. [19] report that among patients with a LOS greater
than 4 days, additional days account for a relatively small
share of the total cost for the entire stay. However, for simplic-
ity, in the base-case scenario, we assume constant costs per in-
patient day regardless of LOS. Thus, the estimated inpatient
cost of an unexpected hospitalization is $6500 ($2600/d times
2.5 days).
Finally, as shown in Table 3, assumptions about the
characteristics of the treatment population are taken from the
study by Memtsoudis et al. and estimates of life expectancy
at various ages by gender are taken from the Social Security
Administration actuarial tables [20]. In the base-case model,
the impact of unexpected hospitalization on health-related
quality of life is assumed to operate via the temporary disabil-
ity associated with hospitalization. In an alternative scenario,
the potential impact of partial disability during a postdischarge
recovery period is examined. The potential for any long-termor permanent disability or other signiﬁcant and persistent ad-
verse health effects associated with an unexpected disposition
is not accounted for in the model.3. Results
For the base-case model, as shown in Table 4, average es-
timated anesthesia-related treatment costs (including costs of
unexpected dispositions) over a 1-year period were $807 per
ambulatory procedure for anesthesia administered by physi-
cian anesthesiologists, compared with $776 for NAs and
$750 for a physician anesthesiologist/NA team (1:4 ratio). In
terms of effectiveness, there were an estimated 6.9% unexpect-
ed dispositions for NAs, compared with 4.6% for physician
anesthesiologists and 4.8% for teams. Focusing on QALYs,
the expected value of QALYs in the base-case model is
0.0004 lower for NA treatment compared with physician
anesthesiologist treatment (or about 0.15 quality-adjusted
days, or about 3.5 quality-adjusted hours). Turning to cost-
effectiveness ratios, the estimated cost per unexpected hospi-
talization avoided is $1325 for physician anesthesiologist
treatment vs NA treatment, and the estimated incremental cost
per QALY gained is about $77,400 in the base-case scenario.
Table 3 Parameter assumptions, effectiveness (life-years,
QALYs)
Base Sources
Treatment cohort
Age (%)
20-44 45.6% [12]
45-64 43.3% [12]
65+ 11.1% [12]
Sex (male, %) 54.9% [12]
Knee (%) 81.3% [12]
Shoulder (%) 18.7% [12]
QALYs
Life expectancy at age 32 y (2011)
Male 45.9 [21]
Female 50.0 [21]
Life expectancy at age 55 y (2011)
Male 25.4 [21]
Female 28.7 [21]
Life expectancy at age 70 y (2011)
Male 14.1 [21]
Female 16.3 [21]
HR-QoL (utility) decrement (year 1)
Unexpected admission
Decrement 0.0139 A
Decrement/inpatient day (%) 100% A
Decrement/postdischarge day (%) 25% A
Death 1 A
QALYs = quality-adjusted life-years; HR-QoL = health-related quality of
life; A = authors' assumption.
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tive parameter assumptions where guidance from the literature
is lacking. One-way sensitivity analyses, reported in Table 5,
are used to assess the impact of a change in an assumed param-
eter value on estimated cost effectiveness. For example, as not-
ed in the study by Memtsoudis et al. death was too rare of an
outcome of ambulatory surgery to analyze, given the study
sample size. However, Silber et al. [9] found higher rates ofTable 4 Cost-effectiveness summary
Cost and effectiveness Expected costs
Physician anesthesiologist–alone $807
Physician-directed NA—1:4 $750
NA-alone $776
Cost-effectiveness ratios (vs NA-alone)
NA-alone
Physician-directed NA—1:4
Physician anesthesiologist–alone
QALYs = quality-adjusted life-years; NA = nurse anesthetist; UnexpAdm = unexpdeath when anesthesia care was not directed by physician
anesthesiologists. If the same relative risk ratio used for
unexpected disposition is also applied to the risk for death,
the estimated incremental cost per QALY gained falls to
about $17,400.
For those patients experiencing an unexpected hospitaliza-
tion, it may be plausible to assume that they would not have
completely recovered from the cause for their hospitalization
at the date of their discharge. Accounting for the potential for
modest follow-up treatment costs and for the disutility of
post-discharge health effects lowers the estimated cost per
QALY gained to about $15,900 (for 5-day postdischarge re-
covery time) or about $6600 (for 10-day recovery time).
The estimated differential between professional service
costs for NAs vs physician anesthesiologists is an inﬂuential
parameter in the cost analysis. Abouleish et al. [21] report that
NAs billed the Texas Medicaid program for more units of an-
esthesia time compared with physician anesthesiologists.
Thus, our base-case assumption regarding relative profession-
al service costs may be excessively favorable for NAs. If NA
professional services costs are assumed to be 5% higher than
in the base case, the incremental cost per QALY falls to
$54000, and if NA professional services costs are assumed
to be 15% higher than in the base case, the incremental cost
per QALY falls to $7200. Indeed, if the cost of NA profession-
al services is at least 17% higher than in the base case, provi-
sion of outpatient anesthesia by physician anesthesiologists
is cost saving compared with NA administration.
A key element affecting both costs and outcomes in the
model is the likelihood of an occurrence of an unexpected dis-
position and the magnitude of the cost and health impact of an
unexpected disposition event. Fig. 1 provides a 2-way sensitiv-
ity graph for 2 parameters: (1) the ﬁrst parameter affects the
likelihood of an unexpected disposition associated with type
of anesthesia provider (ie, the assumed excess risk for NA),
and (2) the second parameter affects the conditional magnitude
of the event (mean inpatient costs for unexpected hospitaliza-
tion). The orange-dashed lines represent the base-case param-
eter values of 100% and $6500/hospitalization. If the assumed
cost per hospitalization is $6000, and the assumed excess riskEffectiveness
Year 1
UnexpAdm QALYs
4.57% 0.9965
4.85% 0.9964
6.90% 0.9961
Δ$/UnexpAdm Δ$/QALY
– –
Cost saving Cost saving
$1325 $77,400
ected admission.
Table 5 Summary of 1-way sensitivity analyses
Cost-effectiveness ratios (physician vs NA) Δ$/UnexpAdm Δ$/QALY
Base case $1325 $77,400
Same RRs for death, NA vs physician 1220 17,400
Postdischarge costs and disutility (5 d) 1225 15,900
Postdischarge costs and disutility (10 d) 1125 6600
Base-case NA professional service cost +5% 924 54,000
Base-case NA professional service cost +10% 524 30,600
Base-case NA professional service cost +15% 123 7200
Base-case NA professional service cost +20% Cost saving Cost saving
NA = nurse anesthetist; UnexpAdm = unexpected admission; RR = relative risk.
161Cost of unexpected disposition by anesthesia provideris 100% of the value reported in the study byMemtsoudis et al.
then the estimated incremental cost per QALY gained for phy-
sician vs NA anesthesia administration is about $100,000.
Similarly, if the assumed excess risk is 95% of the base-case
value and the cost per hospital stay is $7000, then the estimat-
ed incremental cost per QALY gained is about $75,000. In
general, lower assumed excess risk associated with NA-only
administration and lower assumed costs per hospitalization
yield higher incremental cost/QALY estimates.4. Discussion
The base-case model results suggest that compared with
ambulatory shoulder and knee procedures with physician-
administered anesthesia, procedures with NA-administered
anesthesia would result in an additional 2.3 unexpected
dispositions per 100 procedures. Total anesthesia-related costs
(including the costs of managing unexpected dispositions) for
physician-administered anesthesia is estimated to be about $31
higher per procedure than NA-administered anesthesia. Thus,
the estimated incremental cost per unexpected disposition
avoided using physician anesthesiologist vs NA-administered
anesthesia is $1375 in the base-case model.Fig. 1 Two-way sensitivity analysis: % of base-case NA excess
risk for unexpected disposition andmean hospital cost per unexpected
hospitalization. NA = nurse anesthetist.The estimated cost per QALY gained is about $77,400 in
the base-case model. This result is mainly attributable to the
small estimated impact of unexpected dispositions on QALYs
in the base-case model, which in turn is attributable to the in-
frequency of unexpected disposition coupled with the assump-
tion that all disutility effects are transitory and resolve within 1
year. However, it is possible that some complications resulting
in unexpected disposition (and not resulting in death) have
treatment costs and health effects that persist for more than 1
year. This possibility was not assessed in any of our sensitivity
analyses, but accounting for potential long-term or permanent
effects on health-related quality of life would reduce the esti-
mated cost per QALY gained over a time horizon exceeding
1 year.
The base-case model is likely to overestimate the cost per
unexpected disposition avoided and cost per QALY gained,
using physician vs NA-administered anesthesia. There are a
number of elements of the consequences of unexpected dispo-
sitions (such as temporary partial disability immediately after
hospital discharge) with plausible cost or health-related quality
of life implications, but none of these are accounted for in the
base-case model due to a lack of evidence relating to the mag-
nitude of the effects. In sensitivity analyses, when conservative
assumptions about the magnitude of such effects are incorpo-
rated into the model, the estimated incremental cost per
QALY gained falls well below $50,000 per QALY gained.
Although “$50,000/QALY” often is cited as a threshold for
acceptable cost-effectiveness, as Neumann et al. [22] note, no
one really knows the original source of the $50,000 bench-
mark, or why the ﬁgure has been used unchanged for decades,
without even an adjustment for inﬂation. Simply adjusting for
inﬂation from 1980 to 2014 would make the oft-cited standard
$144,000/QALY. Hirth et al. [23] use estimates from the
literature examining the value of a “statistical” life in an
attempt to produce an evidence-based threshold value. When
focusing on safety-related revealed preference studies,
they conclude that the median value of a QALY implied by
estimates of the willingness to pay for a statistical life
was $265,000 in 1997 dollars ($391,000 in 2014 dollars).
Similarly, Braithwaite et al. [24] report an estimated
willingness to pay threshold of $183,000 to $264,000 per
QALY in 2003 dollars ($235,000–$340,000 in 2014 dollars).
162 R.L. Ohsfeldt et al.Even our base-case estimate of cost per QALY gained falls
well below these revised benchmarks. However, although
Neumann et al. conclude that the traditional benchmark is
almost certainly too low, they caution that any single
benchmark value is unlikely to be appropriate across different
settings for value assessments.
Prior studies have shown that ambulatory knee and
shoulder procedures are less likely to result in an unexpected
disposition if anesthesia is administered by physician anesthe-
siologists compared with NAs. Although professional service
costs are higher for physician anesthesiologists compared with
NAs, these higher costs are partially offset by costs of manag-
ing additional unexpected dispositions with NAs. Overall, the
improvement in outcomes associated with anesthesia adminis-
tered by physician anesthesiologists is attained at a reasonable
additional cost, based on updated cost-effectiveness bench-
mark thresholds, and may be cost saving under some model
scenarios. If future studies replicate this ﬁnding in other surgi-
cal settings, current policies promoting greater reliance on
NAs operating independently (without physician anesthesiolo-
gist supervision) may need to be reevaluated.References
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